MEDP's logo.
Ticker Symbol: MEDP

Medpace Holdings Inc

$224.88 - 20-12-2024 4 p.m. ET

Exchange: NASDAQ Country: US Currency: USD Asset Type: Common Stock CIK:0001668397

Company Profile

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace's mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 3,400 people across 37 countries.

Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
Standard Industrial Classification Code (SIC code): 8731
Address: 5375 Medpace Way
CEO: August Troendle
Tags:
  • Commercial Services
  • Miscellaneous Commercial Services

Pricing

Last Updated: October 13, 2023 03:00 PM EST
Previous Close: $239.10
Change: $1.04 ( 0.44%)
Days Range: $234.20 - $240.52
Beta: 1.25
52wk. High: $282.73
52wk. Low: $155.84
Ytd. Change 13.00%
50 Day Moving Average: $251.95
200 Day Moving Average: $233.40
Shares Outstanding: 30562773

Valuation

Market Cap: 730.8B
PE Ratio: 28.57
EPS (TTM): 8.37

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A